Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(155 sites)

United States

City of Hope Medical Center, Duarte, California

Valkyrie Clinical Trials, Los Angeles, California

Georgia Cancer Center, Augusta, Georgia

Northshore University Health System-Evanston Hospital, Evanston, Illinois

Carle Cancer Center, Urbana, Illinois